Akorn, Inc. Investors Encouraged to Contact Securities Law Firm about Investigation into Allegations of Corporate Wrongdoing

NEW YORK, March 4, 2015 /PRNewswire/ -- Securities lawyers at Dunnam & Dunnam are investigating allegations for Akorn, Inc. shareholders (NASDAQ: AKRX). Concerned AKRX investors who purchased between April 17, 2014 and March 2, 2015 are encouraged to contact securities attorney Hamilton Lindley by clicking here.

The law firm's investigation will focus on potential violations of the federal securities laws.  Akorn announced on March 2, 2015 that "the Company filed a Form 12b-25, Notification of Late Filing with the SEC that allows them to extend the deadline to file its Form 10-K for the year ended December 31, 2014. The Company has experienced unforeseen delays in collecting and compiling certain financial and other related data that would be included in the Form 10-K relating to the VersaPharm and Hi-Tech Pharmacal subsidiaries which were not integrated into Akorn's centralized accounting department and accounting systems as of December 31, 2014." Share of Akorn are down $5.37 per share, on this news, or approximately 10%, currently trading at $48.34 on March 3, 2015.

Dunnam & Dunnam has significant experience representing shareholders in securities lawsuits nationwide. AKRX stockholders – or anyone with knowledge about this situation – should contact lawyer Hamilton Lindley at [email protected] with questions, toll free at (844) 702-2990 or visit http://www.dunnamlaw.com/AKRX.

Find these Waco personal injury attorneys, trucking accident attorneys and car wreck attorneys on Google+, Facebook, Twitter and LinkedIn.

SOURCE Dunnam & Dunnam

Related Links

http://www.dunnamlaw.com